What If You Invested in SPDR S&P Biotech ETF (XBI)?

XBI

XBI seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index. Calculate historical returns with real market data.

What if you invested $1000 in XBI on Jan 1, 2020?

Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.

📈
Your investment journey awaits!
Click "Calculate Investment" to see your potential returns
Current Value
$XX,XXX
Return
+XXX%
CAGR
X.XX%
vs SPY
+XX%

Historical Annual Returns

Over the past 20 years, SPDR S&P Biotech ETF has delivered an average annual return of 12.7%. The stock peaked in 2020 with a massive +49.0% gain, while investors faced a downturn in 2022 (-28.1%). Overall, the stock finished in the green 12 times out of 20 years.

Avg Return

+12.7%

Win Rate

60%

12W - 8L

Best

+49.0%

2020

Worst

-28.1%

2022

Performance Consistency

12 Positive8 Negative

About SPDR S&P Biotech ETF

Visit Website ↗

XBI seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.

HeadquartersBoston, USA
Founded2006-01-31

Key Business Segments

ETF

US Biotech Equities